24.01.2013 Views

marks published for opposition - U.S. Patent and Trademark Office

marks published for opposition - U.S. Patent and Trademark Office

marks published for opposition - U.S. Patent and Trademark Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MAY 1, 2012 U.S. PATENT AND TRADEMARK OFFICE TM 547<br />

CLASS 5—(Continued).<br />

SN 85-480,414. KYTHERA BIOPHARMACEUTICALS, INC.,<br />

CALABASAS, CA. FILED 11-23-2011.<br />

THE MARK CONSISTS OF STANDARD CHARACTERS<br />

WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,<br />

SIZE, OR COLOR.<br />

FOR PHARMACEUTICAL PREPARATIONS FOR RE-<br />

DUCING OR REMOVING LOCALIZED FAT. PHARMA-<br />

CEUTICAL PREPARATIONS FOR NON-SURGICAL<br />

REMOVAL OF FAT ACCUMULATION UNDER THE<br />

CHIN OR SUB-MENTAL FAT. PHARMACEUTICAL<br />

PREPARATIONS FOR NON-SURGICAL FACIAL CON-<br />

TOURING OR FACIAL SCULPTING (U.S. CLS. 6, 18, 44,<br />

46, 51 AND 52).<br />

SHAUNIA CARLYLE, EXAMINING ATTORNEY<br />

SN 85-480,479. KYTHERA BIOPHARMACEUTICALS, INC.,<br />

CALABASAS, CA. FILED 11-23-2011.<br />

THE MARK CONSISTS OF STANDARD CHARACTERS<br />

WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,<br />

SIZE, OR COLOR.<br />

FOR PHARMACEUTICAL PREPARATIONS FOR RE-<br />

DUCING OR REMOVING LOCALIZED FAT. PHARMA-<br />

CEUTICAL PREPARATIONS FOR NON-SURGICAL<br />

REMOVAL OF FAT ACCUMULATION UNDER THE<br />

CHIN OR SUB-MENTAL FAT. PHARMACEUTICAL<br />

PREPARATIONS FOR NON-SURGICAL FACIAL CON-<br />

TOURING OR FACIAL SCULPTING (U.S. CLS. 6, 18, 44,<br />

46, 51 AND 52).<br />

SHAUNIA CARLYLE, EXAMINING ATTORNEY<br />

SN 85-480,647. HARMON, WILLIAM W.E., TEXAS CITY, TX.<br />

FILED 11-24-2011.<br />

THE MARK CONSISTS OF STANDARD CHARACTERS<br />

WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,<br />

SIZE, OR COLOR.<br />

FOR DIETARY AND NUTRITIONAL SUPPLEMENTS;<br />

DIETARY SUPPLEMENT BEVERAGE FOR BOOSTING<br />

ENERGY; DIETARY SUPPLEMENTAL DRINKS; HER-<br />

BAL MALE ENHANCEMENT CAPSULES; HERBAL<br />

SUPPLEMENTS; NUTRITIONAL SUPPLEMENTS FOR<br />

BOOSTING ENERGY IN THE FORM OF DRINKS (U.S.<br />

CLS. 6, 18, 44, 46, 51 AND 52).<br />

GINA FINK, EXAMINING ATTORNEY<br />

CLASS 5—(Continued).<br />

SN 85-480,758. NATURE’S NUTRITIONAL LABS LLC, DAL-<br />

LAS, TX. FILED 11-25-2011.<br />

NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO<br />

USE "BABY FORMULA", APART FROM THE MARK AS<br />

SHOWN.<br />

THE MARK CONSISTS OF THE WORDING "NATURE’S<br />

BABY FORMULA" WHEREIN THE APOSTROPHE IS DE-<br />

PICTED AS A HEART DESIGN, FLANKED BY TWO<br />

STYLIZED LEAF DESIGNS, ALL INSIDE A RECTANGU-<br />

LAR SHAPED BANNER WITH SHADING ALONG THE<br />

UPPER LEFT AND LOWER RIGHT CORNERS.<br />

FOR BABY FOOD; INFANT FORMULA (U.S. CLS. 6,<br />

18, 44, 46, 51 AND 52).<br />

FIRST USE 9-1-2011; IN COMMERCE 9-1-2011.<br />

KELLY CHOE, EXAMINING ATTORNEY<br />

SN 85-480,886. NOVARTIS AG, BASEL, SWITZERLAND,<br />

FILED 11-25-2011.<br />

THE MARK CONSISTS OF STANDARD CHARACTERS<br />

WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,<br />

SIZE, OR COLOR.<br />

FOR ANTI-INFLAMMATORIES; ANTIBACTERIAL<br />

PHARMACEUTICALS; ANTIBIOTICS; ANTIFUNGAL<br />

PREPARATIONS; ANTIVIRALS; CARDIOVASCULAR<br />

PHARMACEUTICALS; PHARMACEUTICAL PREPARA-<br />

TIONS ACTING ON THE CENTRAL NERVOUS SYSTEM;<br />

PHARMACEUTICAL PREPARATIONS AND SUB-<br />

STANCES FOR THE TREATMENT OF GASTRO-INTEST-<br />

INAL DISEASES; PHARMACEUTICAL PREPARATIONS<br />

FOR THE TREATMENT AND PREVENTION OF DIS-<br />

EASES AND DISORDERS OF THE AUTOIMMUNE<br />

SYSTEM, THE METABOLIC SYSTEM, THE MUSCULO-<br />

SKELETAL SYSTEM AND THE GENITOURINARY SYS-<br />

TEM; PHARMACEUTICAL PREPARATIONS FOR USE<br />

IN HEMATOLOGY AND IN TISSUE AND ORGAN<br />

TRANSPLANTATION; PHARMACEUTICAL PREPARA-<br />

TIONS FOR THE TREATMENT OF EYE DISEASES AND<br />

CONDITIONS; PHARMACEUTICAL PREPARATIONS<br />

FOR THE TREATMENT OF HEART RHYTHM DISOR-<br />

DERS; PHARMACEUTICAL PREPARATIONS FOR THE<br />

TREATMENT OF IMMUNE SYSTEM RELATED DIS-<br />

EASES AND DISORDERS; PHARMACEUTICAL PRE-<br />

PARATIONS FOR THE TREATMENT OF KIDNEY<br />

DISEASES; PHARMACEUTICAL PREPARATIONS FOR<br />

TREATING DIABETES; PHARMACEUTICAL PREPARA-<br />

TIONS FOR USE IN DERMATOLOGY; PHARMACEUTI-<br />

CAL PRODUCTS FOR OPHTHALMOLOGICAL USE;<br />

PHARMACEUTICAL PRODUCTS FOR THE PREVEN-<br />

TION AND TREATMENT OF CANCER; PHARMACEU-<br />

TICAL PRODUCTS FOR THE TREATMENT OF BONE<br />

DISEASES; PHARMACEUTICAL PRODUCTS FOR<br />

TREATING RESPIRATORY DISEASES; PHARMACEU-<br />

TICAL PRODUCTS FOR TREATING RESPIRATORY<br />

DISEASES AND ASTHMA; PHARMACEUTICALS,<br />

NAMELY, ANTI-INFECTIVES (U.S. CLS. 6, 18, 44, 46, 51<br />

AND 52).<br />

AMY C. KEAN, EXAMINING ATTORNEY

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!